Table 2.
Incidence of neurological manifestations according to sex in the Brazilian COVID Registry Project, 2020–2022 (n = 13,603).
| Neurological manifestation | Overalla (N = 13,603) n(%) | Mena (N = 7211) n(%) | Womena (N = 6392) n(%) | p-valueb |
|---|---|---|---|---|
| Headache | 2705 (19.9%) | 1275 (17.7%) | 1430 (22.4%) | <0.001 |
| Ageusia | 1275 (9.4%) | 643 (8.9%) | 632 (9.9%) | 0.056 |
| Anosmia | 1110 (8.2%) | 561 (7.8%) | 549 (8.6%) | 0.091 |
| Delirium | 834 (6.1%) | 409 (5.7%) | 425 (6.6%) | 0.020 |
| Syncope | 133 (1.0%) | 69 (1.0%) | 64 (1.0%) | 0.861 |
| Coma | 68 (0.5%) | 36 (0.5%) | 32 (0.5%) | >0.999 |
| Stroke | 27 (0.2%) | 16 (0.2%) | 11 (0.2%) | 0.647 |
| Seizures | 39 (0.3%) | 26 (0.4%) | 13 (0.2%) | 0.121 |
| Peripheral neuropathy | 10 (0.1%) | 8 (0.1%) | 2 (0.0%) | 0.116 |
a
Statistics are presented as n (%)
b
Statistical tests performed: chi-square test of independence; Fisher's exact test.